Georgia

Opinion

Invest in Domestic Manufacturing to Onshore America’s Biotech Supply Chain

As the U.S. moves away from reliance on Chinese CDMOs, Southern cities provide a model for how we can bolster domestic production capacity.

August 14, 2024

5 min read

Josh Carpenter

Business

Atlanta’s Biotech Scene Prepares for New Heights

The Atlanta area is receiving more physical real estate options to foster its burgeoning biotech industry.

May 1, 2024

6 min read

Tyler Patchen

PRESS RELEASES

Press Releases

Clearside Biomedical’s Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit

March 21, 2025

7 min read

Press Releases

Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations

March 19, 2025

6 min read

Press Releases

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital

March 19, 2025

5 min read

Press Releases

Dogwood Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy-Induced Neuropathic Pain

March 19, 2025

4 min read

Press Releases

Walter J. ‘Wally’ Curran, Jr., M.D., Named Whitaker Endowed Chief of Piedmont Oncology

March 18, 2025

2 min read

Press Releases

Avanos Medical Announces Appointment of David Pacitti as Chief Executive Officer

March 17, 2025

2 min read

Press Releases

Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

March 13, 2025

5 min read

Press Releases

Epilepsia Publishes Final Analysis of Open-Label Extension Study of Long-Term Safety and Effectiveness of FINTEPLA® (fenfluramine) in Children and Adults with Dravet Syndrome

March 13, 2025

20 min read

Press Releases

Clearside Biomedical to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on Thursday, March 27, 2025

March 12, 2025

2 min read

Press Releases

Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward

March 12, 2025

6 min read

Press Releases

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital

March 11, 2025

6 min read

Press Releases

Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13th International RSV Symposium

March 10, 2025

3 min read

Press Releases

BIMZELX® (bimekizumab-bkzx) Five-Year Data at AAD 2025 Showed Sustained Skin Clearance and Long-Term Efficacy in Moderate-to-Severe Plaque Psoriasis

March 10, 2025

21 min read

Press Releases

Clearside Biomedical Announces Successful End-of-Phase 2 Meeting with the FDA and Alignment on Phase 3 Plans for Suprachoroidal CLS-AX in Wet AMD

March 7, 2025

7 min read

Press Releases

LIPOGEMS ANNOUNCES ENROLLMENT OF THE FINAL PATIENT IN ARISE FDA CLINICAL TRIALS FOR KNEE OSTEOARTHRITIS

March 5, 2025

2 min read

Press Releases

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

March 4, 2025

5 min read

Press Releases

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference

February 27, 2025

1 min read

Press Releases

MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results

February 27, 2025

24 min read

Press Releases

Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results

February 26, 2025

29 min read

Press Releases

Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital

February 26, 2025

5 min read